Who
Jonathan Provoost
EVP, Chief Legal Officer
Company insider
Files Form 4 as: EVP, Chief Legal Officer, Amarin Corporation.
In numbers
- Trades disclosed
- 18
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 Dec 2023
- Last trade
- 1 Jul 2026
- Last filed
- 15 Jul 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Jul 2026filed 15 Jul 2026 | AMRN Amarin CorporationBiotechnology | SEC FORM 4 Code M | —3,688 | filing |
| 1 Jul 2026filed 15 Jul 2026 | AMRN Amarin CorporationBiotechnology | SEC FORM 4 Code F | $20K1,264 at $15.94 | filing |
| 1 Jul 2026filed 15 Jul 2026 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,688 at $0.00 | filing |
| 1 Jul 2026filed 15 Jul 2026 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,688 at $0.00 | filing |
| 1 Jul 2026filed 15 Jul 2026 | AMRN Amarin CorporationBiotechnology | SEC FORM 4 Code M | —3,688 | filing |
| 1 Jul 2026filed 15 Jul 2026 | AMRN Amarin CorporationBiotechnology | SEC FORM 4 Code F | $20K1,264 at $15.94 | filing |
| 1 Feb 2026filed 3 Feb 2026 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,013 at $0.00 | filing |
| 1 Feb 2026filed 3 Feb 2026 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code A | —36,060 at $0.00 | filing |
| 1 Feb 2026filed 3 Feb 2026 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,013 at $0.00 | filing |
| 1 Feb 2026filed 3 Feb 2026 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code A | —36,060 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | AMRN Amarin CorporationBiotechnology | SEC FORM 4 Code M | —3,688 | filing |
| 2 Jan 2026filed 6 Jan 2026 | AMRN Amarin CorporationBiotechnology | SEC FORM 4 Code F | $21K1,488 at $13.96 | filing |
| 2 Jan 2026filed 6 Jan 2026 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,688 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,688 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | AMRN Amarin CorporationBiotechnology | SEC FORM 4 Code M | —3,688 | filing |
| 2 Jan 2026filed 6 Jan 2026 | AMRN Amarin CorporationBiotechnology | SEC FORM 4 Code F | $21K1,488 at $13.96 | filing |
| 10 Jan 2025filed 10 Jan 2025 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code A | —663,878 at $0.00 | filing |
| 1 Dec 2023filed 5 Dec 2023 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code A | —800,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.